Sex: U
Vaccine: DTAP, DTAPIPV, DTPPVHBHPB, FLU4, HIBV, IPV, MNQ, TD, TDAP, UNK
Symptoms: Medication error, Product storage error
Clinical narrative: Excursion occurred due to refrigerator door being left open total time out of range is 15 minutes and highest temperature recorded is 47.1 Fahrenheit with no AE; Initial information received on 18-Nov-2021 regarding an unsolicited non-valid non-serious case received from an other health professional.   This case was invalid as unidentifiable patient involved.  This case involves an unknown age and unknown gender patient for whom it was reported "excursion occurred due to refrigerator door being left open total time out of range is 15 minutes and highest temperature recorded is 47.1 fahrenheit  for following vaccine VAXELIS, INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV], MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE [MENQUADFI], DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [TENIVAC], DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [QUADRACEL], DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE [PENTACEL (VERO)], DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL], DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL], HIB (PRP/T) VACCINE [ACT-HIB] and IPV (VERO) [IPOL] and while treated with TUBERCULIN TEST [TUBERSOL].  The patient medical history, medical treatment(s), vaccination(s), concomitant medication, and family history were not provided.  On an unknown date, the patient started taking TUBERSOL (TUBERCULIN TEST) Solution for injection dosage unknown (with an unknown batch number and expiry date) for Tuberculin test. On an unknown date, the patient received a dose of suspect HIB (PRP/T) VACCINE [lot number and expiry date not reported] via an unknown route in unknown administration site for prophylactic vaccination. On an unknown date, the patient received a dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [lot number and expiry date not reported] via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient received a dose of suspect DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [lot number and expiry date not reported] via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient received a dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE [lot number and expiry date not reported] via an unknown route in unknown administration site for prophylactic vaccination. On an unknown date, the patient received a dose of suspect DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [lot number and expiry date not reported] via an unknown route in unknown administration site for prophylactic vaccination. On an unknown date, the patient received a dose of suspect DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [lot number and expiry date not reported] via an unknown route in unknown administration site for prophylactic vaccination. On an unknown date, the patient received a dose of suspect MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE [lot number and expiry date not reported] via an unknown route in unknown administration site for prophylactic vaccination. On an unknown date, the patient received a dose of suspect VAXELIS not produced by Sanofi Pasteur [lot number and expiry date not reported] via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE [lot number and expiry date not reported] via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient received a dose of suspect IPV (VERO) [lot number and expiry date not reported] via an unknown route in unknown administration site for prophylactic vaccination.  It was case of medication error due to product storage error on 18-NOV-2021 [Latency: on the same day].  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  There will be no information available on the batch number for this case.